Other companies may be struggling to meet expectations for financial performance, but not Varian Medical Systems. On April 8, the company said its earnings for 2Q 2003 would rise 35% to 40% over the year-ago quarter. Previously, the company estimated 26%
Other companies may be struggling to meet expectations for financial performance, but not Varian Medical Systems. On April 8, the company said its earnings for 2Q 2003 would rise 35% to 40% over the year-ago quarter. Previously, the company estimated 26% growth for the quarter. The better-than-expected earnings reflect a recovery much stronger than was anticipated in the x-ray products business, according to Varian. The company is also reporting continued strength in its oncology business. The strong quarter puts annual company earnings per diluted share for fiscal 2003 on track to grow by 29% to 31% over fiscal 2002 totals.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.